Technical and Clinical Validation of the WPM-SEMG Prototype

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Neuron Disease, Motor
Interventions
DEVICE

WPM-SEMG prototype

Measurements will be done with the rigid matrix. The flexible electrode matrix will be used only on a lower percentage of volunteers depending on the results obtained with the rigid matrix

Trial Locations (1)

6900

RECRUITING

Neurocentro della Svizzera Italiana, Lugano

All Listed Sponsors
collaborator

University of Applied Sciences and Arts of Southern Switzerland

OTHER

collaborator

Clinical Trial Unit Ente Ospedaliero Cantonale

OTHER

lead

Alain Kaelin

OTHER

NCT06584084 - Technical and Clinical Validation of the WPM-SEMG Prototype | Biotech Hunter | Biotech Hunter